☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
first patient dosing
Dermavant Reports the First Patient Dosing in P-III ADORING Program of Tapinarof for the Treatment of Atopic Dermatitis
September 10, 2021
Caribou Reports the First Patient Dosing in P-I ANTLER Study of CB-010 to Treat Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
July 14, 2021
Henlius Reports First Patient Dosing in P-II/III Study of HLX10 + HLX04 (biosimilar- bevacizumab) for 1L mCRC
March 11, 2021
Henlius Reports First Patients Dosing in P-I Study of HLX14 (denosumab- biosimilar)
November 11, 2020
Henlius Reports First Patient Dosing with HLX11 (biosimilar- pertuzumab) for HER2-Positive Metastatic Breast Cancer and Early Brea...
September 20, 2020
Bicycle Reports First Patient Dosing in P-IIa Study of BT1718 for MT1-MMP-Positive Squamous NSCLC
September 3, 2020
Oncoinvent Reports the First Patient Dosing with Radspherin in its P-II Clinical Evaluation for Ovarian Cancer
October 10, 2024
Cybrexa Therapeutics Doses the First Patient with CBX-12 Under P-II Study for Treating Ovarian Cancer
October 7, 2024
Satellos Reports the First Patient Dosing with SAT-3247 in P-I Trial for Duchenne Muscular Dystrophy
September 19, 2024
Phanes Therapeutics Reports the First Patient Dosing with PT886 in P-I/II Study for Pancreatic and Gastric Cancer
September 10, 2024
OncoC4 Reports the First Patient Dosing in P-I Study of ONC-841 for Solid Tumors
September 5, 2024
ALX Oncology Reports the First Patient Dosing in P-I/II (UMBRELLA) Trial of Evorpacept Plus Sarclisa for Treating R/R Multiple Mye...
September 5, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.